Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen

PURPOSE: The management of patients with advanced/metastatic adrenocortical carcinoma (ACC) is challenging, EDP-M (etoposide, doxorubicin, cisplatin combined with mitotane) is the standard regimen. However, it is quite toxic, so an adequate supportive therapy is crucial to reduce as much as possible...

Descripción completa

Detalles Bibliográficos
Autores principales: Turla, Antonella, Laganà, Marta, Grisanti, Salvatore, Abate, Andrea, Ferrari, Vittorio Domenico, Cremaschi, Valentina, Sigala, Sandra, Consoli, Francesca, Cosentini, Deborah, Berruti, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385801/
https://www.ncbi.nlm.nih.gov/pubmed/35567656
http://dx.doi.org/10.1007/s12020-022-03075-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385801/
https://www.ncbi.nlm.nih.gov/pubmed/35567656
http://dx.doi.org/10.1007/s12020-022-03075-y

Ejemplares similares